Arterial Blood Gas Kits Market Size Report & Share Outlook 2030

The arterial blood gas kits market is expected to reach US$ 1,213.05 million by 2030 from US$ 695.67 million in 2022. The market is estimated to grow with a CAGR of 7.2% from 2022 to 2030.

Market Insights and Analyst View:

An arterial blood gas (ABG) is a blood test carried out by taking blood from an artery, rather than a vein. It is performed so that an accurate measurement of oxygen and carbon dioxide levels can be obtained, which then allows the oxygen to be delivered appropriately. The ABG kits include a needle protection sheath that cores the bevel and encapsulates the contaminated needle to prevent blood spatter. The integral safety clips on the syringe allow for audible and visual confirmation that the needle is secure. Arterial syringes are available non-vented or with a rear vented system which automatically evacuates air out the back of the syringe as the blood fills during the draw. Arterial blood gas tests are also performed on patients in respiratory distress, such as an asthma attack. Factors such as the increasing prevalence of respiratory diseases and metabolic and kidney diseases are driving the market growth. However, risks, complications, and sampling errors associated with arterial blood sampling hinder the market growth.

Growth Drivers and Opportunities:

Chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and other respiratory diseases are creating a huge burden on the public healthcare system in various countries across the world. Smoking, infections, and genetic factors can cause serious respiratory complications. In 2021, The American Lung Association reported that COPD is the third leading cause of death in the US, and over 16.4 million people are diagnosed with the condition. According to the Asthma and Allergy Foundation of America, ∼26 million people in the US had asthma in 2022, which is one of the most common respiratory diseases in the world. As per the World Health Organization (WHO), pneumonia accounted for 14% of the total deaths (i.e., 740,180 deaths) of children below the age of 5 years across the world in 2019. Patients suffering from respiratory disorders usually experience breathing issues and oxygen shortages. Arterial blood gas (ABG) test is carried out to measure the amount of oxygen and carbon dioxide dissolved in arterial blood. The test helps deliver care to patients suffering from acute and chronic respiratory disease. Thus, the growing prevalence of acute and chronic respiratory diseases propels the demand for arterial blood gas test kits.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Arterial Blood Gas Kits Market: Strategic Insights

Market Size Value in	US$ 695.67 million in 2022
Market Size Value by	US$ 1,213.05 million by 2030
Growth rate	CAGR of 7.2% from 2022 to 2030
Forecast Period	2022-2030
Base Year	2022

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Report Segmentation and Scope:

Based on product, the arterial blood gas kits market is segmented into Luer Lock syringe and Luer Slip syringe. In terms of type, the arterial blood gas kits market is segmented into non-vented and vented. The arterial blood gas kits market, by usage, is bifurcated into pre-set plunger mode and manual aspiration. Based on application, the arterial blood gas kits market is segmented into in vitro diagnostics, electrolyte analysis, and pH blood gas. By needle gauge, the arterial blood gas kits market is segmented into 23G to 25G and less than 23G. In terms of syringe volume, the arterial blood gas kits market is segmented into 1 ml, 3 ml, and others. Based on end user, the arterial blood gas kits market is segmented into hospitals, clinics , and others. By geography, the arterial blood gas kits market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Segmental Analysis:

The arterial blood gas kits market, by product, is bifurcated into luer lock syringe and luer slip syringe. The luer lock syringe segment held a larger market share in 2022 and is anticipated to register a higher CAGR of 7.9% during the forecast period. A luer lock syringe features a standardized, threaded tip called a luer lock. One of the primary advantages of luer lock syringes is their ability to provide a tight, leak-free, secure, and reliable connection. The threaded design allows a firm twist-lock mechanism that prevents accidental detachment, ensuring the safety of both patients and healthcare professionals during medical procedures. This feature is particularly important in situations that involve the administration of medications or fluids, where a secure connection is crucial to prevent leaks or contamination. Furthermore, luer lock syringes offer versatility and compatibility with a wide range of medical devices. Standardized luer lock fittings are widely adopted in healthcare settings, making it easy to interchange different components without specialized connectors. This interoperability allows healthcare professionals to select and connect the appropriate accessories based on specific patient needs, ensuring efficient and effective treatment.

By application, the arterial blood gas kits market is categorized into in vitro diagnostics, electrolyte analysis, and pH blood gas. The in vitro diagnostics segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 7.8% during the forecast period. Arterial blood gas (ABG) kits play an important role in vitro diagnostics (IVD) by providing valuable information about a patient's respiratory and metabolic status. These kits are designed to measure and analyze the levels of electrolytes, pH, partial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2), bicarbonate (HCO3), and base excess (BE) from arterial blood samples, which helps healthcare professionals assess a patient's acid-base balance, oxygenation, and overall respiratory function. ABG kits are commonly used in critical care settings, such as intensive care units (ICUs), emergency departments, and operating rooms, where close monitoring of a patient's respiratory status is essential. They are especially valuable in managing patients undergoing anesthesia. The results obtained from ABG analysis can aid in the diagnosis and management of various conditions, such as chronic lung diseases, respiratory failure, chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and metabolic disorders.

By end user, the arterial blood gas kits market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022. However, the clinics segment is anticipated to register the highest CAGR of 7.8% during the forecast period. The hospitals segment holds a significant share of the arterial blood gas kits market. The adoption of arterial blood gas kits is higher in hospitals as they provide healthcare facilities with specialized scientific equipment. In addition, the hospitals offer advanced diagnosis and treatment options for patients to treat their acute and chronic conditions under health policies. Moreover, they are the primary centers for patients seeking first aid or highly advanced treatment. Also, the growing number of hospital admissions, increasing usage of advanced arterial blood gas kits, and rising funds for improving facilities at hospitals drive the arterial blood gas kits market growth for the hospitals segment.

Access Data

Regional Analysis:

North America dominates the global arterial blood gas kits market. The North America arterial blood gas kits market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North American arterial blood gas kits market in 2022. The growth of the arterial blood gas kits market is primarily driven by public awareness regarding blood sampling kits and the increasing number of research and collaboration to explore innovative therapeutic applications. The market in the region is also likely to spur with the presence of various key players in the market. In addition, the adoption of medical devices in healthcare operations for improving quality and reducing costs is also responsible for augmenting the growth of the arterial blood gas kits market in North American countries. Furthermore, the Asia Pacific arterial blood gas kits market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to be the fastest growing among all the regions. The market growth is attributed to the rising awareness regarding kidney and respiratory diseases among the countries such as India, Australia, and South Korea and the developing medical device industry and respiratory sector in countries, including Japan and China.

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global arterial blood gas kits market are listed below:

1. In May 2022, Becton, Dickinson and Company (BD) and Babson Diagnostics expanded their strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing. Plans under the expanded agreement include continuing research and development to enable self-collection, mobile services, and at-home collection.
2. In April 2022, Siemens Healthineers received US Food and Drug Administration approval for RAPIDPoint 500e Blood Gas Analyzer. RAPIDLyte Arterial Sampling Syringes and RAPIDLyte Multicap Capillaries offered by Siemens are compatible with RAPIDPoint 500e Blood Gas System. This product approval strengthens the market position of the company.
3. In February 2020, Becton, Dickinson and Company (BD) and Babson Diagnostics entered into a long-term strategic partnership agreement. The partnership helps to develop and deliver standard laboratory-quality, small-volume arterial blood gas collection kits such as BD Vacutainer at retail pharmacies. The partnership allows the company to build its distribution network to increase product penetration in the respective markets.

COVID-19 Impact:

The COVID-19 pandemic has created vital growth opportunities for the arterial blood gas kit market. The market has experienced exponential growth during the pandemic due to tremendous demand for oxygen level testing through arterial blood gas kits. North America is the leading market that has significantly contributed to the growth of the market. There have been various factors, including increased incidences of COVID-19-positive patients, growth in arterial blood gas kit technologies, increasing production of kits, etc. The cases majorly led to the demand for arterial blood gas kits testing in the countries such as the US, Canada, and Mexico. For instance, according to the WHO, till July 12, 2021, 74,091,960 confirmed cases of COVID-19 had been registered in the Americas. Also, the Americas has registered 1,945,985 deaths. The incidences indicate the number of arterial blood gas kit tests required in the US alone. Similarly, other countries have experienced a rise in the incidences of COVID-19 positive, which increased the demand for arterial blood gas kits testing. The other major factor that has driven the market growth is developments for arterial blood gas kits. Various product approvals are gaining traction in the market. The FDA has increased its efforts to support the health of people and has imposed several guidelines for hospitals and medical device companies. Various companies also enhanced their research and development activities for diagnostics tests and therapeutic devices. Thus, increased production by the companies has resulted in profits, and the outbreak of COVID-19 has shown a positive impact on the market growth.

Competitive Landscape and Key Companies:

A few of the prominent players operating in the global arterial blood gas kits market include Becton Dickinson and Co; Vyaire Medical Inc; Opti Medical Systems; ICU Medical; SunMed LLC; Trudell Healthcare Solutions Inc; Siemens Healthineers AG; Radiometer Medical ApS; ITL Health Group Ltd; Medline Industries LP; Cardinal Health Inc; Fisher Scientific International, Inc.; and Teleflex Inc. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share. The report offers a trend analysis of the arterial blood gas kits market, emphasizing various parameters such as technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.